回盛生物(300871) - 2025 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2025 reached ¥399,068,578.25, representing a 92.96% increase compared to ¥206,809,092.09 in the same period last year[5] - Net profit attributable to shareholders was ¥44,496,959.41, a significant turnaround from a loss of ¥16,405,616.80, marking a 371.23% increase[5] - Basic earnings per share rose to ¥0.2684 from a loss of ¥0.0989, indicating a 371.39% improvement[5] - Total operating revenue for the current period reached ¥399,068,578.25, a significant increase from ¥206,809,092.09 in the previous period, representing a growth of approximately 92.7%[26] - Net profit for the current period was ¥44,777,497.12, a turnaround from a net loss of ¥16,405,616.80 in the previous period[28] - Earnings per share (EPS) for the current period was ¥0.2684, compared to a loss per share of ¥0.0989 in the prior period[29] Cash Flow - The net cash flow from operating activities improved to ¥57,960,264.16, compared to a negative cash flow of ¥46,279,493.65 in the previous year, reflecting a 225.24% increase[5] - Cash inflow from operating activities totaled ¥332,255,252.14, up from ¥224,327,944.23 in the previous period, reflecting a growth of approximately 48.2%[29] - The cash flow from operating activities showed resilience despite challenges in investment and financing activities, highlighting operational strength[30] - The company continues to focus on managing cash flows effectively amid fluctuating investment returns and financing conditions[30] Assets and Liabilities - Total assets increased by 1.04% to ¥3,046,149,776.08 from ¥3,014,682,865.02 at the end of the previous year[5] - Total current assets increased to ¥1,346,009,223.51 from ¥1,312,585,417.22, reflecting a growth of about 2.5%[22] - Total liabilities decreased to ¥1,461,121,229.57 from ¥1,549,479,748.16, a reduction of about 5.7%[24] - Total equity increased to ¥1,585,028,546.51 from ¥1,465,203,116.86, representing a growth of approximately 8.2%[24] - The company’s total non-current liabilities decreased to ¥513,027,212.71 from ¥626,164,645.33, a decline of approximately 18.1%[24] Investment and Financing Activities - The company reported a significant increase in investment income, with a fair value change gain of ¥8,711,382.63, compared to a loss of ¥18,092,751.86 in the previous year, marking a 148.15% improvement[12] - Total cash inflow from investment activities was $96,164,407.02, down from $183,452,284.70, while cash outflow for investment activities was $223,629,940.01, resulting in a net cash flow of -$127,465,532.99, worsening from -$76,332,192.37[30] - Cash inflow from financing activities totaled $124,116,220.00, a decrease from $202,776,473.00, while cash outflow was $87,759,468.86, down from $107,572,170.13, leading to a net cash flow of $36,356,751.14, compared to $95,204,302.87 previously[30] Shareholder Information - The total number of common shareholders at the end of the reporting period is 14,229[16] - Wuhan Tongsheng Investment Co., Ltd. holds 48.38% of shares, totaling 82,800,000 shares, with 6,200,000 shares pledged[16] Future Plans and Management - The company plans to continue expanding its product sales, which significantly contributed to the revenue growth in the current quarter[12] - The company has triggered the conditional redemption clause for the "Hui Sheng Convertible Bonds" due to stock price conditions being met[18] - The company plans to exercise its right for early redemption of the convertible bonds, as approved by the board of directors[18] - The company plans to implement new accounting standards starting in 2025, which may impact future financial reporting[32] - The board of directors remains committed to strategic financial management to enhance shareholder value and operational efficiency[33] Other Financial Metrics - The company experienced a 238.42% increase in taxes payable, amounting to ¥9,545,304.92, primarily due to increased corporate income tax and VAT[11] - The company reported accounts receivable of ¥415,047,080.15, an increase from ¥368,367,475.80, representing a growth of about 12.6%[21] - The company’s inventory decreased slightly to ¥244,328,189.32 from ¥248,164,158.72, a decline of approximately 1.5%[21] - The company’s fixed assets decreased to ¥1,505,027,290.50 from ¥1,525,198,068.46, a reduction of about 1.3%[22] - The company’s cash and cash equivalents decreased to ¥271,699,911.85 from ¥326,144,663.23, a decline of approximately 16.7%[21] - The ending balance of cash and cash equivalents was $151,847,660.83, down from $201,749,381.84, reflecting a decrease in liquidity[31] - The company reported a total cash outflow of $32,744,282.41 for the period, which is a slight increase from the previous outflow of $27,762,907.55[31] - The company has not yet audited its first-quarter report, indicating that the financial results are still subject to review[32]